RE:IMO the FDA was and is supportive of MCNA..so BMRN a very big company MarketCap $15B (down $1.5B on this news) and FDA signalling no likely approval on DMD and it falls 10% whilst SRPT is up +25%...
..complete evidence that FDA signalling results in very strong market action (of course of AdCom votes yes the price action will be reversed)
..so back to TST, IMO had the FDA been messaging its lack of support of MCNA the briefing documents would've reflected it and IMO TST would've cratered to $0.50 or lower before AdCom, instead the stable price going in (ignore the silly blowoff to $1.00 on goofy Japan spec) which i concluded before AdCom that the market like i had read FDA support